Biotech GC Biopharma’s Recombinant Anthrax Vaccine, BARYTHRAX, Demonstrates Safety and Immunogenicity in Phase 2 Data, Published in ‘Vaccine’ November 4, 2025
Biotech Zhimeng Biopharma’s investigational drug CB03-154 for amyotrophic lateral sclerosis has achieved the first patient first dose milestone in the phase 2/3 pivotal clinical trial. November 3, 2025
Biotech StimLabs® Announces New Real-World Study Demonstrating Positive Outcomes Using Relese® in the Treatment of Chronic Wounds November 2, 2025
Biotech Hansa Biopharma Reports Third Quarter and Interim Year to Date 2025 Financial Results October 31, 2025
Biotech NLS Pharmaceutics and Kadimastem Announce Completion of Material Conditions Precedent for Merger Transaction and Delisting Date of Kadimastem’s Shares October 30, 2025
Biotech NLS Pharmaceutics Ltd. Announces 1-for-10 Reverse Share Split and Name Change in Connection with Proposed Merger with Kadimastem October 29, 2025
Biotech Inside information: Bioretec is revising its financial targets, deems that the current financial targets will not be met and withdraws its financial targets October 28, 2025
Biotech Published in The Lancet: Nipocalimab significantly decreased Sjögren’s disease (SjD) activity and severity through substantial reduction in Sjögren’s-related autoantibodies October 27, 2025
Search
Biotech
November 4, 2025
November 3, 2025
November 2, 2025
November 1, 2025
October 31, 2025
October 30, 2025
October 29, 2025
October 28, 2025
October 27, 2025
October 26, 2025
